$4.94
+0.00 (+0.00%)
Open$4.88
Previous Close$4.94
Day High$5.01
Day Low$4.80
52W High$11.89
52W Low$3.16
Volume—
Avg Volume389.1K
Market Cap67.21M
P/E Ratio—
EPS$-4.33
SectorPharmaceuticals
Analyst Ratings
Strong Buy
9 analysts
Price Target
+191.1% upside
Current
$4.94
$4.94
Target
$14.38
$14.38
$9.95
$14.38 avg
$17.66
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 8.37M | 8.17M | 9.32M |
| Net Income | 2.92M | 2.10M | 3.15M |
| Profit Margin | 34.9% | 25.8% | 33.8% |
| EBITDA | 4.25M | 3.98M | 4.18M |
| Free Cash Flow | 2.06M | 2.44M | 3.61M |
| Rev Growth | +14.6% | -6.6% | +11.6% |
| Debt/Equity | 0.37 | 0.32 | 0.41 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,107.08 | +0.45% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $239.08 | +3.37% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $119.60 | +3.57% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.72 | -1.44% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.53 | +1.52% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $76.84 | +1.25% | 12.5 | 33.00B |